FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
Microsoft and Health-ISAC Oct. 15 announced that they disrupted three cybercriminal businesses that provided services to threat actors to attack more than 75,…
Headline
The AHA will host a webinar Oct. 20 at 1 p.m. ET that will explore the evolving voice threat landscape — including voice phishing, or vishing, spoofing and…
Headline
A new critical vulnerability has been discovered in Citrix NetScaler ADC and NetScaler Gateway products, the company announced Oct 8. Citrix said the…
Chairperson's File
What does patient safety mean to you? For many, patient safety means what we can see: hand hygiene, infection prevention and control practices, medication…
Headline
A joint advisory released Oct. 8 by U.S. and international agencies warns of Chinese government-linked cyber threat actors using automated and hands-on hacking…
Headline
The National Security Agency Oct. 8 released guidance for critical infrastructure organizations that recommends adopting high-impact zero trust strategies to…